Award-winning network operating system provides a 50% Total Cost Savings over 400G Solutions from legacy equipment vendors
SANTA CLARA, Calif., November 13, 2024 – IP Infusion, a global software leader in open networking solutions, today announced significant features and upgrades to its OcNOS Data Center product for cloud service providers, telco clouds, and other advanced data center applications. These new features increase the value proposition of OcNOS, already the market leader in independent networking software platforms, and offer performance parity to systems costing twice as much, such as offerings from legacy equipment vendors.
The OcNOS Data Center networking software provides a feature-rich EVPN-VxLAN fabric solution that is deployment proven. Demand for higher bandwidth driven by data-heavy applications and increased backhaul traffic volumes for 5G and edge computing necessitates high-performance networking software, a market in which IP Infusion pioneered the first networking software product to be successfully commercialized in the late 1990s. Since then, the OcNOS networking operating system has become the most successful and popular independent networking software platform on the market today.
IP Infusion's network automation, orchestration, and management integration support provides flexibility for data centers:
- IP Maestro Element Management System to manage OcNOS devices via GUI-based point-and-click networking
- IP Infusion OcNOS Ansible Collection for command-line automation integration
- NETCONF programmable API with Yang data models
- gNMI based streaming and subscription-based telemetry with Yang data models
- IP Infusion Zabbix SNMP template enables discovery and monitoring of OcNOS devices
"For 25 years, we have been developing OcNOS to be a performance-first software product. IP Infusion's reputation as the most popular independent networking platform across the globe is built on our field-tested domain expertise, which has been proven time and again in diverse use cases," said Atsushi Ogata, President and CEO of IP Infusion. "Customers with 400G data center upgrades will benefit from OcNOS' software performance and flexibility with total cost savings."
IP Infusion provides world-class 24×7 tech support as well as comprehensive product documentation available online. For more information about OcNOS for 400G data center upgrades, including supported hardware platforms and 400G ZR/ZR+ optics, read our blog.
Chi è IP Infusion
IP Infusion manufactures open network software and solutions for carriers, service providers, and data centers. With hundreds of customers and thousands of deployments, IP Infusion is a market leader in Network Operating Systems. Our flagship software platform, OcNOS®, allows network operators to disaggregate their networks, streamline operations, and reduce Total Cost of Ownership (TCO). Network OEMs may also disaggregate network devices to expedite time to market, offer comprehensive services, and achieve carrier-grade robustness.
IP Infusion is headquartered in Santa Clara, Calif., and is a wholly owned and independently operated subsidiary of ACCESS CO., LTD. Additional information can be found at http://www.IPInfusion.com.
-end-
Media Contact:
Katherine Verducci, 1903 PR
408.429.5779
Chi è IP Infusion
IP Infusion è un fornitore leader di software di open networking e offre OcNOS, un sistema operativo di rete carrier-grade per service provider, data center e reti fabric AI. Con esperienza nel networking dal 1999 e oltre 600 operatori nel mondo, IP Infusion abilita un'infrastruttura di rete aperta, multi-vendor, efficiente nei costi e flessibile su hardware aperto validato di partner come Edgecore Networks, UfiSpace e Celestica. IP Infusion è una controllata al 100% di ACCESS CO., LTD. (Borsa di Tokyo: 4813).
Contatto stampa
For press inquiries, analyst briefings, or media materials, please contatti il nostro team or email pr@ipinfusion.com.
Dichiarazioni previsionali
Questo comunicato può contenere dichiarazioni previsionali relative a prodotti, tecnologie e piani di IP Infusion. Le dichiarazioni previsionali si basano sulle informazioni disponibili alla data di pubblicazione e comportano rischi e incertezze. I risultati effettivi possono differire. Piani di prodotto, funzionalità, tempistiche di rilascio e disponibilità sono soggetti a modifiche senza preavviso e non costituiscono un impegno, una promessa o un obbligo legale. IP Infusion non assume alcun obbligo di aggiornare le dichiarazioni previsionali.